Data-based information on individual health risks
Your health data - better used, well protected
With the new Health Data Utilization Act (GDNG), statutory health insurance companies will in future be allowed to evaluate certain health data not only for billing purposes, but also for the early detection of individual health risks (Section 25b SGB V). The aim is to improve your care - by providing targeted information on potential health problems.
At the same time, data protection is safeguarded: you retain control over your data and can object to this use at any time.
Using data sensibly - for your health
The GDNG allows us to specifically evaluate certain health data - for example, to draw your attention to possible risks or missed preventive care. This allows illnesses to be detected earlier and gaps in care to be closed.
Possible application examples:
- Early detection of rare or serious diseases
- Recommendations for early cancer detection
- Warnings about problematic medication combinations
- Indications of impending need for care
- Detection of serious risks, such as stroke risks
- Reminders of recommended vaccinations
Data is used strictly in accordance with legal requirements - exclusively for your support and as a decision-making aid. Whether and how you react is always your decision, together with your doctor.
Your right to object
You decide whether your data may be used for evaluations in accordance with Section 25b SGB V. If you do not want this, you can object to the use - either completely or only for individual areas of application.
You have 4 weeks to object before we analyze your data for the first time. You can also object at any time thereafter. Your decision will not result in any advantages or disadvantages for you. Please note: If you switch to another health insurance company, you will have to submit your objection again there.
Submitting an objection to the use of health data
Legal basis
The legal basis for the use of data is Section 25b SGB V, which was introduced by the Health Data Utilization Act. It allows us as a health insurance company to specifically evaluate certain data - exclusively for the purpose of health protection. This enables us to draw your attention to possible risks and support your health care.
Excerpt from the legal text:
The health and long-term care insurance funds may carry out data-based evaluations for the health protection of an insured person and inform the insured person of the results of this evaluation, insofar as the evaluations serve the following purposes:
- in the detection of rare diseases,
- for the detection of cancer
- for the detection of serious health risks that may arise from drug therapy.
- for the detection of a need for care not yet established in accordance with Section 14 of Book Eleven.
- in the detection of similarly serious health risks, insofar as this is in the overriding interest of the insured person from the point of view of the health and long-term care insurance funds.
- in recognizing the existence of vaccination indications for vaccinations recommended by the Standing Vaccination Commission in accordance with Section 20 (2) of the Infection Protection Act.